Display options
Cite
Kavitha N, De S, Kanagasabai S. Oral Hypoglycemic Agents in pregnancy: An Update. J Obstet Gynaecol India. 2013;63(2):82-7doi: 10.1007/s13224-012-0312-z.
Kavitha, N., De, S., & Kanagasabai, S. (2013). Oral Hypoglycemic Agents in pregnancy: An Update. Journal of obstetrics and gynaecology of India, 63(2), 82-7. https://doi.org/10.1007/s13224-012-0312-z
Kavitha, Nagandla, et al. "Oral Hypoglycemic Agents in pregnancy: An Update." Journal of obstetrics and gynaecology of India vol. 63,2 (2013): 82-7. doi: https://doi.org/10.1007/s13224-012-0312-z
Kavitha N, De S, Kanagasabai S. Oral Hypoglycemic Agents in pregnancy: An Update. J Obstet Gynaecol India. 2013 Apr;63(2):82-7. doi: 10.1007/s13224-012-0312-z. Epub 2013 Mar 27. PMID: 24431611; PMCID: PMC3664692.
Copy Download .nbib Format: NLM
Share it on

J Obstet Gynaecol India. 2013 Apr;63(2):82-7. doi: 10.1007/s13224-012-0312-z. Epub 2013 Mar 27.

Oral Hypoglycemic Agents in pregnancy: An Update.

Journal of obstetrics and gynaecology of India

Nagandla Kavitha, Somsubhra De, Sachchithanantham Kanagasabai

Affiliations

  1. Department of Obstetrics and Gynecology, Melaka Manipal Medical College, Jalan Batu Hampar, 75150 Bukit Baru, Melaka Malaysia.

PMID: 24431611 PMCID: PMC3664692 DOI: 10.1007/s13224-012-0312-z

Abstract

INTRODUCTION: Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic agents as an alternative to insulin therapy.

OBJECTIVES: This review examines and evaluates the evidences on the efficacy, safety, and current recommendations of oral hypoglycemic agents.

CONCLUSION: The evidence of this study supports the use of glyburide and metformin in the management of Type 2 diabetes and gestational diabetes with no increased risk of neonatal hypoglycemia or congenital anomalies. The safety of these oral hypoglycemic agents are limited to the prenatal period and more randomized controlled trials are required to provide information on the long-term follow up on neonatal and cognitive development.

Keywords: Gestational diabetes mellitus; Oral hypoglycemic agents; Type 2 diabetes

References

  1. Fertil Steril. 2001 Jan;75(1):46-52 - PubMed
  2. N Engl J Med. 2008 May 8;358(19):1991-2002 - PubMed
  3. J Clin Endocrinol Metab. 2002 Feb;87(2):524-9 - PubMed
  4. J Matern Fetal Neonatal Med. 2002 Apr;11(4):218-25 - PubMed
  5. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):807-12 - PubMed
  6. Fertil Steril. 2005 Apr;83(4):955-8 - PubMed
  7. Obstet Gynecol. 2004 Mar;103(3):526-33 - PubMed
  8. Diabet Med. 2004 Apr;21(4):354-7 - PubMed
  9. Prim Care Diabetes. 2010 Oct;4(3):173-80 - PubMed
  10. Biochem J. 2005 Aug 1;389(Pt 3):913-8 - PubMed
  11. Am J Obstet Gynecol. 2000 Feb;182(2):313-20 - PubMed
  12. Hum Reprod. 2002 Nov;17(11):2858-64 - PubMed
  13. Ann Intern Med. 2002 Jul 2;137(1):25-33 - PubMed
  14. Obstet Gynecol Clin North Am. 2007 Jun;34(2):255-74, ix - PubMed
  15. Pharmacol Res. 1994 Oct-Nov;30(3):187-228 - PubMed
  16. Arch Dis Child. 1974 Apr;49(4):283-91 - PubMed
  17. Ann Intern Med. 1999 Aug 17;131(4):281-303 - PubMed
  18. Diabetes Care. 1998 Aug;21 Suppl 2:B91-8 - PubMed
  19. Diabetes Care. 2009 Jan;32 Suppl 1:S13-61 - PubMed
  20. Circulation. 2011 Jan 25;123(3):258-65 - PubMed
  21. J Matern Fetal Neonatal Med. 2002 Dec;12(6):362-4 - PubMed
  22. Clin Pharmacol Ther. 2003 Jan;73(1):71-7 - PubMed
  23. Am J Obstet Gynecol. 2006 Jul;195(1):270-4 - PubMed
  24. N Engl J Med. 2000 Oct 19;343(16):1134-8 - PubMed
  25. Arch Dis Child. 1970 Oct;45(243):696-701 - PubMed
  26. Diabetes Care. 1991 Aug;14(8):724-7 - PubMed
  27. Fertil Steril. 2002 Mar;77(3):520-5 - PubMed
  28. Gen Pharmacol. 1993 Nov;24(6):1299-309 - PubMed
  29. Clin Pharmacokinet. 2003;42(4):303-13 - PubMed
  30. Fertil Steril. 2001 Nov;76(5):1057-9 - PubMed
  31. Obstet Gynecol. 2002 Nov;100(5 Pt 1):925-30 - PubMed
  32. Diabetes. 1984 Sep;33(9):838-45 - PubMed
  33. Reprod Toxicol. 2001 May-Jun;15(3):227-9 - PubMed
  34. Am J Obstet Gynecol. 2004 May;190(5):1438-9 - PubMed
  35. Diabetes. 1987 Nov;36(11):1320-8 - PubMed
  36. J Perinat Med. 2005;33(6):519-23 - PubMed
  37. N Engl J Med. 2008 May 8;358(19):2003-15 - PubMed
  38. Obstet Gynecol. 2006 Jun;107(6):1303-9 - PubMed
  39. Diabetes Care. 2011 Oct;34(10):2279-84 - PubMed
  40. BMJ. 2000 Jul 29;321(7256):252-3 - PubMed
  41. Clin Obstet Gynecol. 2000 Mar;43(1):106-15 - PubMed
  42. Am J Obstet Gynecol. 1997 Mar;176(3):527-30 - PubMed
  43. Diabetologia. 2002 Nov;45(11):1509-14 - PubMed
  44. Diabetes. 2002 Sep;51(9):2796-803 - PubMed
  45. Endocr Pract. 2007 Jul-Aug;13(4):427-8 - PubMed
  46. Diabetes. 1991 Dec;40 Suppl 2:35-8 - PubMed
  47. JAMA. 2001 Nov 28;286(20):2516-8 - PubMed
  48. J Diabetes Sci Technol. 2009 May 01;3(3):562-7 - PubMed
  49. Am J Obstet Gynecol. 1994 Sep;171(3):653-60 - PubMed
  50. Diabetes Res Clin Pract. 2007 Jun;76(3):474-5 - PubMed
  51. Expert Opin Investig Drugs. 2003 Jul;12(7):1179-87 - PubMed
  52. Ginecol Obstet Mex. 2000 Jan;68:42-5 - PubMed
  53. Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):51-63 - PubMed
  54. Obstet Gynecol. 2001 Sep;98(3):525-38 - PubMed

Publication Types